Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

MyNCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1981 1
1982 1
1985 2
1986 1
1987 4
1988 5
1989 4
1990 7
1991 9
1992 8
1993 8
1994 13
1995 11
1996 15
1997 10
1998 25
1999 32
2000 37
2001 40
2002 50
2003 63
2004 72
2005 74
2006 106
2007 115
2008 162
2009 197
2010 236
2011 296
2012 338
2013 376
2014 448
2015 441
2016 491
2017 583
2018 636
2019 721
2020 151
Text availability
Article attribute
Article type
Publication date

Search Results

5,132 results
Results by year
Filters applied: . Clear all
Page 1
DsbA-L ameliorates high glucose induced tubular damage through maintaining MAM integrity.
Yang M, et al. EBioMedicine 2019. Among authors: Xiao Y, Xiao L. PMID 31060900 Free PMC article.
Disulphide-bond A oxidoreductase-like protein (DsbA-L), expressed in the MAM, serves as an antioxidant and reduces ER stress. ...These alterations were further exacerbated in diabetic DsbA-L gene-deficient mice (DsbA-L(-/-)). In vitro, overexpression of DsbA-L in HK-2 cells restored MAM integrity and reduced apoptosis induced by high-glucose ambience. ...
Disulphide-bond A oxidoreductase-like protein (DsbA-L), expressed in the MAM, serves as an antioxidant and reduces ER stress. ...Thes …
Outcomes of patients with metastatic clear-cell renal cell carcinoma treated with second-line VEGFR-TKI after first-line immune checkpoint inhibitors
Shah AY, et al. Eur J Cancer 2019. Among authors: Xiao L. PMID 31075726
As 1L therapy, 12 patients (17%) received anti-programmed death ligand-1 (PD-(L)1) monotherapy with nivolumab or atezolizumab, 33 (47%) received nivolumab plus ipilimumab and 25 (36%) received combination anti-PD-(L)1 plus bevacizumab. 2L TKI therapies included pazopanib, sunitinib, axitinib and cabozantinib. ...
As 1L therapy, 12 patients (17%) received anti-programmed death ligand-1 (PD-(L)1) monotherapy with nivolumab or atezolizumab, 33 (47 …
A single bacterium restores the microbiome dysbiosis to protect bones from destruction in a rat model of rheumatoid arthritis
Pan H, et al. Microbiome 2019. Among authors: Xiao L. PMID 31315667 Free PMC article.
Treatment of AIA rats with L. casei inhibited joint swelling, lowered arthritis scores, and prevented bone destruction. Along with the relief of arthritis symptoms, dysbiosis in the microbiome of arthritic rats was significantly reduced after L. casei intervention. ...Moreover, L. casei downregulated the expression of pro-inflammatory cytokines, which are closely linked to the effect of the L. casei treatment-associated microbes. ...
Treatment of AIA rats with L. casei inhibited joint swelling, lowered arthritis scores, and prevented bone destruction. Along with th …
5,132 results
Jump to page
Feedback